Building a Future-Proof Safety Strategy With Maestro Multielectrode Array
Fill out the form below and we'll send your colleague an invitation to the "Building a Future-Proof Safety Strategy With Maestro Multielectrode Array" event.
As regulatory momentum accelerates around new approach methodologies (NAMs), toxicology and safety teams are under growing pressure to adopt new technologies without increasing risk.
This webinar examines the scientific and regulatory forces reshaping safety assessment and what they mean for real-world decision making today. Attendees will gain perspective on how leading organizations are navigating this transition and what differentiates NAM platforms that can withstand regulatory scrutiny.
Through real-world context and industry examples, the session highlights how a regulatory-aligned approach such as Maestro multielectrode array (MEA) can support confident, future-ready safety strategies while reducing uncertainty during adoption.
Attend this webinar to:
- Understand why NAMs adoption has reached a true inflection point, driven by recent FDA, EPA, NIH and global regulatory actions signaling a lasting industry shift
- Identify what to expect from a regulatory-ready NAM platform, including predictivity, reproducibility, standardization, scalability and defensibility
- Learn how Maestro MEA reduces adoption risk, drawing on assays used in FDA and US EPA research programs, alongside broad pharma and CRO use and proven return on investment versus animal models
